This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v4.0.0-ballot: STU4 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 3.0.0. For a full list of available versions, see the Directory of published versions
Generated Narrative: MedicationRequest
Resource MedicationRequest "cancer-related-medication-request-gefitinib"
Procedure Intent Extension: Curative - procedure intent (SNOMED CT#373808002)
Normalization Basis Extension: Body surface area (observable entity) (SNOMED CT#301898006)
status: active
intent: order
medication: gefitinib 250 MG Oral Tablet (RxNorm#349472)
subject: Patient/cancer-patient-john-anyperson " ANYPERSON"
authoredOn: 2019-04-01
requester: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"
reasonCode: Non-small cell lung cancer (disorder) (SNOMED CT#254637007)
dosageInstruction
text: 250mg orally once daily with or without food
timing: Code: QD, Events: 2019-04-01, Starting 2019-04-30, Once per 1 days
route: Oral use (SNOMED CT#26643006)
doseAndRate